Haemonetics | HAE - Betriebsaufwand

Aktienkurs
59.19
Täglich Wechseln
-0.37 -0.62%
Monatlich
-7.85%
Jährlich
-3.01%
Q2 Prognose
55.12




Betriebsaufwand Veränderung Datum
Avanos Medical USD 156.13M 2.7M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
Cerus USD 34.78M 2.98M 2024-12
Cooper Companies USD 811.3M 113.5M 2025-12
Fresenius EUR 5.25B 337M 2025-12
Fresenius Medical Care EUR 4.41B 27.91M 2025-12
Globus Medical USD 645.11M 241.46M 2025-12
Haemonetics USD 134.99M 1.26M 2025-12
Hologic USD 349.4M 447.1M 2025-12
ICU Medical USD 514.62M 4.48M 2025-12
Intuitive Surgical USD 2B 263.6M 2025-12
Masimo USD 328.6M 181.6M 2025-12
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Neogen USD 230.07M 4.79M 2025-09
OraSure Technologies USD 40.35M 2.45M 2025-12
Plus Therapeutics USD 7.11M 1.23M 2025-12
Quidel USD 760.9M 1.28B 2025-12
ResMed USD 925.21M 51.98M 2025-12
STAAR Surgical USD 68.74M 1.55M 2025-12
Steris USD 1.22B 28.8M 2025-12
Stryker USD 5.2B 505M 2025-12
Surmodics USD 29.51M 274.86M 2025-06
Teleflex USD 532.64M 3.29B 2025-12
Terumo JPY 252.74B 22.88B 2025-12
Thermo Fisher Scientific USD 9.91B 867M 2025-12
US Physical Therapy USD 185.96M 14.12M 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12